chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received the 2nd dose of Pfizer Wednesday. Thursday I experienced many of the typical side effects: overwhelming exhaustion, pain in the injection arm, dizziness, slight muscle aches and on/off chills without a fever. By Friday, I woke up feeling almost normal. I ran around 11am Friday on my home treadmill and felt fine. Saturday we went for a hike and I felt fine. That afternoon I was tired but nothing terrible. Today, Sunday, I went for a run outside on a route I do often. I went a slow, comfortable pace. I felt good. Then I got to the final hill at the end and felt like something was in my throat, itching it and I needed to cough. I tried to cough lightly at first but it didn't help. I drank from my hydration pack and coughed more deeply. I felt my vision go out a bit and stopped completely. Then suddenly it felt like my lung collapsed and I couldn't breathe. It sounded like I had croup, barely breathing through a wheeze. I was struggling for any oxygen at all, like a clogged straw. I was terrified. It lasted about 20 seconds and then started to ease up.  I was able to get more and more oxygen. It still felt like cobwebs on my lungs,  a tight/heavy feeling for the next 20 minutes or so and then back to normal. I have never experienced something like this before. It was downright terrifying.
Baby received DTAP, IPV, HIB and Prevnar on 1/9/02 and became fussy and febrile and may have had a seizure: brief episode of stiffening, turning slightly blue and a few twitches which lasted 1-2 minutes. According to mom, it stopped before EMS arrived.
Vaccine was given via injection, instead of orally. Patient was monitored for 15 minutes in the clinic as part of routine monitoring after vaccination.
Pfizer COVID-19 vaccine booster was stopped administration two days ago, No symptoms, no side effects.
Pt presents via EMS with altered mental status and reported hypoxia at the nursing facility. Acute hypoxic respiratory failure due to COVID pneumonia along with obstructive sleep apnea, obesity hypoventilation, has been on BiPAP for the past week, emergently intubated, currently with persistent respiratory acidosis and poor oxygenation, remains on sedation and paralytics, discussed with family and they decided to pursue for comfort care. Patient terminally extubated at 1535. Patient time of death 1555. Cause of death is Covid-19, onset 3 weeks. Received decadron.
PATIENT HAVING SEVERE ARM ACHES/PAIN LEADING TO TROUBLE LIFTING ARM UP (CONTINUED ISSUES FOR 2 MONTHS CURRENTLY. TOOK 2 ROUNDS OF STEROID DOSE PACKS TO HELP RESOLVE SOME PAIN).
Very busy immunization clinic.  Besides giving unusual vaccines, it was first day opened to public for flu shots.  I grabbed TDAP and gave to 18 month old instead of DTAP.  Letters too similar or rather same in just different order. Mom said child had diarrhea for 2 days, nothing else.  Moved 2 vaccines to separate shelves in refrigerator.  Had them beside each other before.
Pt stated that he had some mild tingling in his tongue, lip, and chin after his booster vaccine. Stated he had the same reaction with dose 1 and 2.
The SQ site (2"X5") became hard and red the first day.  Then general redness occurred from my upper arm to below my elbow.  My upper arm swelled and was 2 inches bigger in diameter than the right arm.  This stayed hot and swollen unti 4/14/2013.
Headache, fever, diarreah, nausea, and muscle aches. Took Tylenol.
Patient phoned us this morning, to notify us that she had a reaction after her vaccine. Beginning on Saturday the 9th she awoke with slight fever, a red and swollen arm at injection site and some vomiting episodes. She is feeling better now, but wanted to let us know what happened.
This case was reported by a nurse via sales rep and described the occurrence of rash in a 36-year-old male patient who received FLUARIX QUADRIVALENT (batch number K4GP4, expiry date 24th June 2018). Previously administered products included FLUARIX QUADRIVALENT with an associated reaction of no reaction on previous exposure to drug (in 2016). On 5th September 2017, the patient received FLUARIX QUADRIVALENT (intramuscular).5 ml. In September 2017, 2 days after receiving FLUARIX QUADRIVALENT, the patient experienced rash. On an unknown date, the outcome of the rash was unknown. The reporter considered the rash to be related to FLUARIX QUADRIVALENT. Additional details were reported as follows: The patient never had a reaction in the past. The patient received FLUARIX QUADRIVALENT to his left deltoid. The location of the rash was unknown by the sales representative. The sales representative stated that the facility was going to report the adverse event to VAERS.
By the following morning, my daughter had a large and painful lump(s) in her armpit. We called the doctor and were told it was an adverse reaction. We were to start ibuprofen and ice, avoid any touching of the area, and monitor it for a few days. That was Monday, and it is now Friday. The lump is still there but it is slightly less painful. If it isn't better by Monday, we will see the pediatrician.
DIZZINESS; NAUSEA; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. The patient's past medical history included hives, bariatric surgery, and diabetic, and concurrent conditions included lettuce. nuts and unspecified ingredient in indian food allergy, asthma, heart disease, cholesterol problem, ex smoker, allergy of unknown food substance, and non-alcohol user, and other pre-existing medical conditions included the patient did not have any drug abuse, illicit drug use.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 207A21A expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. Concomitant medications included montelukast for asthma, atorvastatin for high cholesterol, famotidine for stomach acid, acetylsalicylic acid, biotin, and cyanocobalamin. On 13-APR-2021, the subject experienced dizziness. On 13-APR-2021, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from dizziness, and nausea. This report was non-serious.
'Had second dose of Pfizer vaccine on 1/13 at 4:30PM. The following morning (1/14), I experienced nausea and light headedness. This resulted in fainting multiple times and be transported to  via ambulance. After receiving fluids, symptoms decreased but continued to have fever/body aches until following day (1/15).'
Within 10 seconds of vaccine pt turned white & fainted. She came to in about 10-15 seconds. Sitting at time of syncope so no injury. 1st BP 105/55 - wait 15 mins 2nd BP 117/96 -> went home with father.
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender. Concurrent therapies were not provided. On 08-JAN-2015, the patient was vaccinated with an improperly stored dose of  GARDASIL "10x1 sdv" (Lot No. K001631, exp. 06-NOV-2016) (dose and site not reported). On an unspecified date, the GARDASIL vaccine had a temperature excursion of 160 hours. The highest recorded temperature was 59 (15 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Child given varicella vaccine 6/5/98. Became ill with varicella 11/26/01 -rash, itching, 25-30 spots only a couple spots blistered & scabbed - Dr said it was varicella - 2 siblings given vaccine in 1999 did not get sick. We have no info on vaccine. Several children in the area had varicella.
Patient  was given vaccine and  had increased  muscle  pain . Patient  went to the Emergency Department on 2/16/22 and  was found to have  rhabdomyolysis.  In hindsight had similar reaction  after  second  COVID vaccine but unclear of the correlation at the time.
Stomach bug; This spontaneous case was reported by a consumer and describes the occurrence of GASTRIC INFECTION (Stomach bug) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. In December 2021, the patient experienced GASTRIC INFECTION (Stomach bug). At the time of the report, GASTRIC INFECTION (Stomach bug) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 test: (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided. No treatment information mentioned.  In 2021, patient got a positive COVID-19 test. In DEC of 2021, got the stomach bug.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
Moderna COVID-19 Vaccine EUA Sore left arm,  swollen lump at injection site.  Arm is still moveable with little or no pain, just the lump is sore.
Localized reaction-right deltoid erythema, warm, slightly raised. 7 cm X 5 cm. slight headaches, fever 99.
feel very terrible/feels horrible; neckache; body aches; light headed; cold chills; nauseous; bad headache; feels very warm; sick; fever; all his previous doses were Moderna this was his first Pfizer dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 47-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Oct2022 as dose number unknown (booster), single (Batch/Lot number: unknown) at the age of 47 years for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Ibuprofen for muscle pain, notes: sometimes take Ibuprofen 200mg for muscle pain. Vaccination history included: Moderna covid-19 vaccine (States all his previous doses were Moderna .), for COVID-19 Immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 11Oct2022, outcome "unknown", described as "all his previous doses were Moderna this was his first Pfizer dose"; PYREXIA (non-serious) with onset 12Oct2022, outcome "unknown", described as "fever"; MALAISE (non-serious), outcome "unknown", described as "feel very terrible/feels horrible"; NECK PAIN (non-serious), outcome "unknown", described as "neckache"; PAIN (non-serious), outcome "unknown", described as "body aches"; DIZZINESS (non-serious), outcome "unknown", described as "light headed"; CHILLS (non-serious), outcome "unknown", described as "cold chills"; NAUSEA (non-serious), outcome "unknown", described as "nauseous"; HEADACHE (non-serious), outcome "unknown", described as "bad headache"; FEELING HOT (non-serious), outcome "unknown", described as "feels very warm"; ILLNESS (non-serious), outcome "unknown", described as "sick". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: the patient had received Gray cap, Original/Omicron BA.4/BA.5 (Bivalent), vaccine. Stated that all his previous doses were Moderna this was his first Pfizer dose. He stated that they usually make him sick, and this was the first Pfizer one he has had the rest were the Moderna. He was asking if he could take Ibuprofen for his experienced side effects. Reported he has a bad headache, feels nauseous and was drinking water most of the day. He had the paperwork that was given to him and stated all fevers made him feel this way and he was wanting to know if he could take Ibuprofen. He wanted to know if his temperature went down, he would feel better. His Cold chills started about 1:30pm and took his temperature and it was 102. Stated this has happened with all the vaccines he had got.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
This case was reported by a nurse and described the occurrence of injection site swelling in a 5 year old male subject who was vaccinated with Infanrix for prophylaxis. On 6/6/05, the subject received the 4th dose of Infanrix in the right arm (lot DTPA614A9). On 6/8/05, 2 days after vaccination, the subject experienced injection site swelling and was seen at a physician's office. The nurse reported that, "the swelling was up to 5cm in the right arm". On 6/13/05, the events resolved. The nurse considered the injection site swelling to possibly be related to vaccination with Infanrix.
Within about 7 hours I started having body aches and severe chills. These lasted for the next 48 hours. I also had a fever of 99.9 for more than 72 hours. My normal temp is typically 97.1-ish, so although 99.9 isn't high, it is more than 2 degrees higher than my normal.
This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: FA6780), intramuscular in left arm, on 06Jun2021 at 08:30 AM, as dose 2, single, for COVID-19 immunization. The patient's medical history included polymyalgia rheumatica from 20Sep2018 and ongoing. The patient's concomitant medication included prednisolone for polymyalgia rheumatica. The patient previously took the first dose of BNT162B2 (Lot Number: ER8733) on 19May2021 at 03:30 PM for COVID-19 immunization (intramuscular in left arm). The patient had no prior vaccinations within 4 weeks. The most recent vaccine was administered in a public health clinic or Veterans administration facility. On 10Jun2021, the patient experienced muscle and joint soreness that was considered serious per persistent or significant disability or incapacity. On or about 10Jun2021 (unspecified), the patient had been down to 5 mg prednisolone daily. Soreness (muscle and joint) returned in hands, arms, shoulders, knees, and ankles. Increased prednisolone to 7 mg helped a little for a few days, soreness returned and is increasing. Treatment included increased dosage of prednisolone. The events required visit and blood test (unknown results in 2021) with the physician. The patient had not recovered from the events.   Follow-up attempts are completed. No further information is expected.
3 minutes after receiving first dose of Pfizer vaccine, patient complaints of numbness and tingling all over his body, shortness of breath, racing heart and he asked multiple times that we call Emergency which we did. on evaluation, patient was in no distress, was calm,. BP was checked and initially was 180/103 and repeated reading was 170/92; heart rate was 92 initially then 103. Denied history of hypertension but admitted to history of anxiety, Paramedics arrived and patient walked and sat in the truck but was later release when he felt better then he left with his wife.
they both felt tired and after a day or two that went away; headache across the eyebrows that was progressively becoming worse; Sinus pressure; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EL9266; Expiration Date: 31May2021), via an unspecified route of administration on 25Feb2021 as single dose for COVID-19 Immunization. Medical history and Concomitant medications were not reported. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EL9266, Expiration Date: 31May2021) on 04Feb2021 single dose for COVID-19 immunization. It was reported that he has developed a headache across the eyebrows that was progressively becoming worse in 2021. He thought it was spring-time allergies at first but never had them before. Patient felt tired in 2021 and after a day or two that went away. He thinks but he doesn't know since he has gotten the second COVID Vaccine, he has been getting headaches, usually in the morning and at night. It's like a sinus headache across his eyebrows. He has never had anything like this in his life. was it common to get a reaction to the vaccine like this? He started getting these headaches and sinus pressure a week or two weeks after getting the second shot in 2021. It was getting worse. Every day it gets worse and worse. Patient states worse time was in the morning when he get up around 7 a.m. and in the evening around 7 p.m. He does use a saline spray, which helps a little. The outcome of event felt tired was recovered in 2021, remaining events were not recovered.  Information on Lot/Batch number was available. Additional information has been requested.
injection site and jaw still sore; face swelling; immediate throat burning; immediate chest burning; My arm was killing me; injection arm hand turned purple/red; unbearable face pain; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (face swelling), THROAT IRRITATION (immediate throat burning), CHEST PAIN (immediate chest burning), LIMB DISCOMFORT (My arm was killing me) and VACCINATION SITE ERYTHEMA (injection arm hand turned purple/red) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Surgery (right jaw joint replacement).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced SWELLING FACE (face swelling), THROAT IRRITATION (immediate throat burning), CHEST PAIN (immediate chest burning), LIMB DISCOMFORT (My arm was killing me), VACCINATION SITE ERYTHEMA (injection arm hand turned purple/red) and FACIAL PAIN (unbearable face pain). On 08-Feb-2021, the patient experienced MYALGIA (injection site and jaw still sore). The patient was treated with FENTANYL ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, SWELLING FACE (face swelling), THROAT IRRITATION (immediate throat burning), CHEST PAIN (immediate chest burning), LIMB DISCOMFORT (My arm was killing me), VACCINATION SITE ERYTHEMA (injection arm hand turned purple/red), FACIAL PAIN (unbearable face pain) and MYALGIA (injection site and jaw still sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment- Benadryl Concomitant medication information was not reported.   Reporter did not allow further contact
1/19 began vomiting and was hospitalized. On 1/30 he was discharged and later received the vaccine. It begins with weakness and a lack of appetite. He started coughing up foul-smelling secretions. He makes the arrangements to take him to the emergency room again, he called 911 to be transported, when they are taking the information from the POC, he is under oxygenation to 44. They take him in the ambulance, he receives CPR, they transport him to the facility where he arrives lifeless.
Headache, Myalgia, Fever,  CHILLS, FATIGUE, SWEATING Narrative:
Information has been received from a nurse referring to an unspecified number of patient of unknown age and gender. The nurse reported that on unspecified dates these patients received improperly stored GARDASIL (Lot# K006960 with expiration date 19-FEB-2017, 0.5ml/once) intramuscularly. No adverse effects were reported. This is one of two reports received from the same reporter (other linked MARRS # 1505USA000532). Additional information has been requested.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (dose and route were not provided). On an unknown date, after receiving ZOSTAVAX, the patient experienced injection site mass (described as a "nod", a large lump at the injection site). The outcome of injection site mass was unknown. The pharmacist advised patient to contact her healthcare provider. Additional information has been requested.
pt recv vax 19MAY95 & 24MAY95 felt achy; that noc found 2 lesions on chest; number of lesions subsequently inc & @ the time of report had about 25; lesions were small & itchy, & the ones on ears were painful
On the day after my second Covid vaccine (03/26/2021) I  had headache and fatigue.  On 04/10/2021, I started noticing a lot of bruising all over my body (petechiae and a lot of other areas of bruising) and I had a lump and pain behind my left calf.  I had some fatigue, but otherwise felt fine. I went to the Emergency Department on April11th thinking that my INR was too high since I?m on a blood thinner medication. The ER did an ultrasound of my legs and no blood clots were found. They did a CBC and I had a platelet count of 6,000. They admitted me, gave me a platelet transfusion and a steroid injection. They discharged me from the hospital on 04/12/2021 on 60 mg of Prednisone and to follow up with my hematologist, MD. My platelet count has since returned to normal.  I am having a CBC once a week and tapering off the Prednisone. Both Dr. and my Rheumatologist, MD believe that my severe drop in platelets were due to the Covid vaccine causing my Lupus to become very active and attack my platelets.  Please feel free to contact me if you have any additional questions. Thanks you,
A nurse reported the occurrence of an injection site reaction in a 5 year old male who was vaccinated with Infanrix for prophylaxis. There was no relevant medical history, concurrent conditions, or concurrent medications. The subject had no adverse experiences following receipt of prior immunizations. On 8/27/02, the subject received his fifth injection of Infanrix (568A9) into the left deltoid. On the same day, he also received an injection of IPOL into the right deltoid. Later that day, an unspecified time post-immunization, the subject developed an injection site reaction characterized by redness and swelling at the Infanrix injection site.